Activating Compound | Comment | Organism | Structure |
---|---|---|---|
L-Dopa | L-DOPA treatment (20-200 microM) increases the levels of dopamine by 226%-504% after 3-6 h of treatment and enhances the activities of tyrosine hydroxylase and aromatic L-amino acid decarboxylase | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
Benserazide | levels of intracellular dopamine after L-DOPA treatment (0.02 and 0.1 mM) are significantly decreased by the AADC inhibitor benserazide (0.02 mM) for 6-24 h exposure prior to L-DOPA treatment in PC12 cells, the 230%-350% increases in dopamine levels by L-DOPA are reduced to 187%-284% by benserazide for 6 h | Rattus norvegicus | |
carbidopa | levels of intracellular dopamine after L-DOPA treatment (0.02 and 0.1 mM) are significantly decreased by the AADC inhibitor carbidopa (0.020 mM) for 6-24 h exposure prior to L-DOPA treatment in PC12 cells, the 230%-350% increases in dopamine levels by L-DOPA are reduced to 187%-284% by 153%-248% by carbidopa for 6 h | Rattus norvegicus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
3,4-Dihydroxyphenylalanine | Rattus norvegicus | L-DOPA, substrate exerts apoptotic cytotoxicity towards PC12 cells at a concentration of 0.1-0.2 mM for 24-48 h | Dopamine + CO2 | major amine neurotransmitter | ? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
PC-12 cell | derived from a pheochromocytoma of the rat adrenal medulla | Rattus norvegicus | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
additional information | - |
110% activity compared to control level, treatment with 0.02 mM L-DOPA in PC-12 cells at 1 h (time point) | Rattus norvegicus |
additional information | - |
237% activity compared to control level, treatment with 0.02 mM L-DOPA in PC-12 cells at 3 h (time point) | Rattus norvegicus |
additional information | - |
242% activity compared to control level, treatment with 0.1 mM L-DOPA in PC-12 cells at 1 h (time point) | Rattus norvegicus |
additional information | - |
269% activity compared to control level, treatment with f 0.1 mM L-DOPA in PC-12 cells at 3 h (time point) | Rattus norvegicus |
additional information | - |
311% activity compared to control level, treatment with 0.2 mM L-DOPA in PC-12 cells at 1 h (time point) | Rattus norvegicus |
additional information | - |
348% activity compared to control level, treatment with 0.2 mM L-DOPA in PC-12 cells at 3 h (time point) | Rattus norvegicus |
additional information | - |
The activity of AADC begins to decrease to about 177% (0.02 mM L-DOPA), 233% (0.1 mM L-DOPA) and 297% (0.2 mM L-DOPA) of the control levels by 3-6 h, and then returns to control level by about 24-48 h | Rattus norvegicus |
0.0325 | - |
activity of AADC, control level without treatment of L-DOPA in PC-12 cells | Rattus norvegicus |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
3,4-Dihydroxyphenylalanine | L-DOPA, substrate exerts apoptotic cytotoxicity towards PC12 cells at a concentration of 0.1-0.2 mM for 24-48 h | Rattus norvegicus | Dopamine + CO2 | major amine neurotransmitter | ? |
Synonyms | Comment | Organism |
---|---|---|
AADC | - |
Rattus norvegicus |
Aromatic L-amino acid decarboxylase | - |
Rattus norvegicus |